Role of COPD in Evaluation of Cardiovascular Risk

被引:1
|
作者
Liu M.A. [1 ]
Lee H.M. [2 ]
机构
[1] Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, 112 Sprague Hall, Irvine, CA
[2] Heart Disease Prevention Program, Division of Cardiology and Pulmonary Medicine, Department of Medicine, University of California, 112 Sprague Hall, Irvine, CA
关键词
Cardiovascular disease (CVD); Chronic obstructive pulmonary disease (COPD);
D O I
10.1007/s12170-013-0292-2
中图分类号
学科分类号
摘要
The association between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) has been documented through a substantial number of studies within the past few decades. This review examines the historical development of pulmonary function as a risk factor for CVD and elucidates on the possible mechanisms of this association prescribed by the contemporary literature. Most data indicates pulmonary inflammation as a substantial factor in the initiation of CVD, but the precise mechanism remains ambiguous. Additionally, COPD often remains misdiagnosed or underdiagnosed due to the lack of apparent symptoms and an adequate classification scheme, exacerbating the high costs of managing this illness. Furthermore, there are no well proven methods for the prevention of COPD outside of smoking cessation. The current literature reveals a discrepancy in the assessment of COPD as a predictor of CVD and highlights a need for future studies. © 2013 Springer Science+Business Media New York.
引用
收藏
页码:113 / 116
页数:3
相关论文
共 50 条
  • [1] Cardiovascular risk detection in COPD
    Bocskei, Renata Marietta
    Benczur, Bela
    Bikov, Andras
    Bocskei, Csaba
    Bohacs, Aniko
    Muller, Veronika
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] COPD: The forgotten cardiovascular risk
    Cochrane, Belinda
    RESPIROLOGY, 2024, 29 (12) : 1013 - 1014
  • [3] History of Cardiovascular Disease and Cardiovascular Risk in People with COPD
    Lemson, A.
    Al Rajah, A.
    Ridsdale, H.
    Ochei, N.
    Nwaneri, B.
    Orr, N.
    Brown, J.
    Hurst, J.
    Aldabayan, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Fibrinogen as a biomarker of cardiovascular risk in COPD
    MacLeod, Mairi
    Ritchie, Andrew
    Wiseman, Dexter
    Finney, Lydia
    Braddy-Green, Aaron
    Shahbakhti, Hassan
    Lopez, Ralph
    Mah, Jordina
    Allinson, James P.
    Donaldson, Gavin C.
    Wedzicha, Jadwiga A.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Mechanisms of Increased Cardiovascular Risk in COPD
    Maclay, J. D.
    McAllister, D. A.
    Mills, N. L.
    Murchison, J. T.
    Newby, D. E.
    MacNee, I. N.
    SCOTTISH MEDICAL JOURNAL, 2009, 54 (01) : 52 - 52
  • [6] Cardiovascular Risk in COPD Searching for a Culprit
    Vivodtzev, Isabelle
    Maltais, Francois
    CHEST, 2020, 157 (04) : 753 - 754
  • [7] Overlooking Cardiovascular Risk in Patients With COPD
    Turner, Richard D.
    Gwavava, Charles M.
    Bianchi, Stephen M.
    CHEST, 2011, 140 (05) : 1385 - 1386
  • [8] Cardiovascular risk and exercise capacity in COPD
    Aldabayan, Yousef S.
    Al Rajah, Ahmed M.
    Aldhahir, Abdulelah
    Lemson, Arthur
    Nava, George
    Brown, Jeremy S.
    Hurst, John R.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [9] Pulmonary Rehabilitation and Cardiovascular Risk in COPD
    Aldabayan, Y.
    Al Rajah, A.
    Lemson, A.
    Ridsdale, H.
    Ochei, N.
    Nwaneri, B.
    Orr, N.
    Brown, J.
    Hurst, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Family Studies: Their Role in the Evaluation of Genetic Cardiovascular Risk Factors
    Mansour-Chemaly, Marianne
    Haddy, Nadia
    Siest, Gerard
    Visvikis, Sophie
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (11) : 1085 - 1096